Home » Newsletters » BioWorld Science

BioWorld Science

June 27, 2016

View Archived Issues

Compugen announces new lead candidate

Kitov Pharmaceuticals reports new data from KIT-302 phase III study

Novel beta-lactamase inhibitor ETX-2514 demonstrates promising in vitro and in vivo efficacy

FADDI-287, a new polymyxin B derivative with improved safety and activity

IMSUT and Astellas sign collaborative development agreement for MucoRice-CTB

Phase I results support daily subcutaneous dosing of Apellis Pharmaceuticals' APL-2

Pfizer completes acquisition of Anacor Pharmaceuticals

Takeda revises Japanese collaboration agreement with Amgen

Janssen Pharmaceutica patents mGlu2 receptor PAMs

Merck & Co. discloses HIV integrase inhibitors

Charles University in Prague describes antituberculosis agents

New Pharma Licence Holdings develops antibacterial agents

Sanofi and Boehringer Ingelheim reach definitive agreements on business exchange

Bayer Schering Pharma presents VEGFR-2 and PDGFR-beta inhibitors

Genticel reports 18-month data from phase II trial of HPV immunotherapeutic candidate

VBI Vaccines cleared to begin phase I study of CMV vaccine candidate in Canada

NIH-supported researchers develop clinical-grade stem cell line

Cellectar Biosciences' CLR-125 shows activity in TNBC xenografts

New phosphate prodrug of alvocidib shows efficacy in mice

EMA's CHMP grants positive opinion to Teva's reslizumab

Regulatory dossier for Sanofi Pasteur's VaxigripTetra approved in Europe

Long-acting amylin analogues ZP-4982 and ZP-5461 improve glycemic control in diabetes model

Gilead Sciences' Odefsey approved in Europe

Cosmo Pharmaceuticals obtains rights to PAION's remimazolam

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...